At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- Doctors still outperform AI in clinical reasoning, study shows (Medical Xpress)
- GLP-1s and the future of obesity care: 4 takeaways on coverage, cost + clinical clarity (Becker’s Healthcare)
- Colonoscopy Capacity Crisis: Time to Embrace Noninvasive Tests? (GI & Endoscopy News)
- 10 GI tech, AI updates to know (Becker’s GI & Endoscopy)
- GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology (PR Newswire)
- Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests (ReachMD)
- New Artificial Intelligence Model Could Speed Rare Disease Diagnosis (Harvard Medical School)
- 13 ways to use technology to boost patient volume at your practice (Physicians Practice)
